Bacil Pharma Limited (BOM:524516)

Bacil Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	717	610	86	32	34	18
Market Cap Growth	290.25%	607.73%	166.97%	-4.36%	83.65%	89.09%
Enterprise Value	701	610	83	28	33	17
Last Close Price	49.95	42.49	14.63	5.48	5.73	3.12
PE Ratio	83.37	150.92	-	-	-	-
PS Ratio	130.85	-	-	-	-	-
PB Ratio	2.72	2.40	7.10	2.94	2.76	1.32
P/TBV Ratio	2.72	2.40	7.10	2.94	2.76	1.32
P/FCF Ratio	-	152.16	-	-	-	-
P/OCF Ratio	-	152.16	-	-	-	-
EV/Sales Ratio	127.94	-	-	-	-	-
EV/FCF Ratio	-	152.28	-	-	-	-
Debt / Equity Ratio	-	0.01	0.08	0.02	0.03	0.13
Debt / FCF Ratio	-	0.41	-	-	-	-
Net Debt / Equity Ratio	-0.06	-0.11	0.05	-0.18	-0.22	-0.04
Net Debt / EBITDA Ratio	-5.20	10.67	-0.30	1.12	1.76	0.39
Net Debt / FCF Ratio	-	-6.72	-19.64	1.35	0.07	0.16
Quick Ratio	-	16.92	0.37	7.87	6.49	0.09
Current Ratio	-	17.21	0.46	8.19	6.69	0.11
Return on Equity (ROE)	-	3.03%	-5.11%	-8.77%	-295.12%	-17.22%
Return on Assets (ROA)	-	-1.18%	-9.62%	-9.37%	-3.70%	-2.54%
Return on Invested Capital (ROIC)	0.94%	-2.09%	-17.40%	-19.41%	-13.92%	-12.52%
Return on Capital Employed (ROCE)	-	-1.00%	-15.60%	-16.30%	-13.00%	-12.00%
Earnings Yield	1.03%	0.66%	-0.69%	-3.16%	-114.37%	-13.02%
FCF Yield	-	0.66%	-0.03%	-4.57%	-118.79%	-21.66%
Buyback Yield / Dilution	-116.22%	-6.92%	1.47%	-1.71%	-0.99%	0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.